Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India · Delayed Price · Currency is INR 212.50
+1.91 (0.91%)
Nov 12, 2026, 3:30 PM IST
NSE:SPARC Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 10,590 | 11.55 | 19.64 | 53.3 | 5.84 | 12.24 |
Short-Term Investments | 2,390 | - | - | 1,500 | 1,110 | - |
Trading Asset Securities | - | - | - | 18.01 | 2,909 | 116.65 |
Cash & Short-Term Investments | 12,981 | 11.55 | 19.64 | 1,571 | 4,025 | 128.89 |
Cash Growth | 137992.55% | -41.17% | -98.75% | -60.96% | 3022.58% | -18.06% |
Accounts Receivable | 213 | 82.71 | 160.57 | 184.03 | 362.31 | 305.65 |
Other Receivables | - | 13.33 | 23.59 | 399.22 | 28.25 | 0.26 |
Receivables | 215.1 | 97.74 | 185.78 | 585.46 | 395.95 | 309.25 |
Inventory | - | 25.14 | 19.54 | 14.79 | 10.66 | 10.78 |
Prepaid Expenses | - | 32.61 | 35.97 | 48.19 | 33.28 | 24.76 |
Other Current Assets | 707.8 | 18,457 | 1.04 | 474.11 | 85.02 | 237.84 |
Total Current Assets | 13,904 | 18,624 | 261.97 | 2,694 | 4,550 | 711.52 |
Property, Plant & Equipment | 844.6 | 856.8 | 992.55 | 1,086 | 1,073 | 951.18 |
Other Intangible Assets | 713.2 | 713.49 | 536.53 | 427.12 | 254.68 | 231.16 |
Long-Term Deferred Tax Assets | 21.3 | 22.68 | 23.09 | 12.62 | - | - |
Other Long-Term Assets | 1,253 | 1,492 | 1,541 | 930.67 | 2,424 | 906.97 |
Total Assets | 16,735 | 21,709 | 3,355 | 5,150 | 8,301 | 2,801 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,006 | 971.52 | 1,139 | 1,423 | 1,483 | 721.87 |
Accrued Expenses | 113.1 | 242.22 | 228.71 | 374 | 175.93 | 147.37 |
Short-Term Debt | - | 5,561 | 1,582 | 470 | 0.51 | - |
Current Portion of Long-Term Debt | - | - | - | - | - | 750 |
Current Portion of Leases | 15.9 | 15.15 | 37.99 | 34.9 | 30.04 | 17.77 |
Current Income Taxes Payable | 0.2 | - | 4.43 | 16.47 | - | - |
Current Unearned Revenue | - | - | 408.98 | 0 | 0.01 | 0.29 |
Other Current Liabilities | 681.7 | 750.77 | 341.2 | 332.29 | 100.44 | 76.99 |
Total Current Liabilities | 1,817 | 7,541 | 3,742 | 2,651 | 1,789 | 1,714 |
Long-Term Debt | - | - | 1,000 | - | - | - |
Long-Term Leases | 8.5 | 16.6 | 69.49 | 106.61 | 126.2 | 24.37 |
Long-Term Unearned Revenue | 333.8 | 625.98 | 625.98 | 1,035 | 1,176 | 668.45 |
Pension & Post-Retirement Benefits | - | 71.68 | 22.42 | - | 11.32 | 18.82 |
Other Long-Term Liabilities | 154.9 | 65.16 | 64.52 | 100.74 | 70.06 | 62.65 |
Total Liabilities | 2,314 | 8,320 | 5,525 | 3,893 | 3,174 | 2,489 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 324.5 | 324.53 | 324.53 | 324.53 | 324.53 | 271.89 |
Additional Paid-In Capital | - | 20,382 | 20,382 | 20,382 | 20,382 | 11,064 |
Retained Earnings | - | -7,324 | -22,876 | -19,449 | -15,578 | -13,366 |
Comprehensive Income & Other | 14,097 | 5.66 | 0.68 | 0.07 | - | 2,343 |
Shareholders' Equity | 14,421 | 13,388 | -2,169 | 1,258 | 5,128 | 312.26 |
Total Liabilities & Equity | 16,735 | 21,709 | 3,355 | 5,150 | 8,301 | 2,801 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 24.4 | 5,593 | 2,689 | 611.51 | 156.75 | 792.14 |
Net Cash (Debt) | 12,956 | -5,582 | -2,670 | 959.8 | 3,868 | -663.25 |
Net Cash Growth | - | - | - | -75.19% | - | - |
Net Cash Per Share | 39.88 | -17.20 | -8.23 | 2.96 | 13.59 | -2.52 |
Filing Date Shares Outstanding | 325.2 | 324.52 | 324.52 | 324.52 | 324.52 | 271.88 |
Total Common Shares Outstanding | 325.2 | 324.52 | 324.52 | 324.52 | 324.52 | 271.88 |
Working Capital | 12,087 | 11,083 | -3,480 | 43.28 | 2,760 | -1,003 |
Book Value Per Share | 44.35 | 41.26 | -6.69 | 3.88 | 15.80 | 1.15 |
Tangible Book Value | 13,708 | 12,675 | -2,706 | 830.44 | 4,873 | 81.1 |
Tangible Book Value Per Share | 42.15 | 39.06 | -8.34 | 2.56 | 15.02 | 0.30 |
Land | - | 80.35 | 80.35 | 80.35 | 80.35 | 80.35 |
Buildings | - | 310.4 | 310.4 | 308.55 | 303.62 | 300.07 |
Machinery | - | 966.44 | 1,000 | 993.88 | 887.9 | 854.83 |
Construction In Progress | - | 4.97 | 5.61 | 12.69 | 18.73 | 37.2 |